Microglia Responses to Pro-inflammatory Stimuli (LPS, IFNγ+TNFα) and Reprogramming by Resolving Cytokines (IL-4,

Starlee Lively1, Lyanne C Schlichter1,2

  • 1Division of Genetics & Development, Krembil Research Institute, University Health Network, Toronto, ON, Canada.

Insights

Microglia reactivity differs between lipopolysaccharide (LPS) and cytokine stimuli. Resolving cytokines like IL-4 show varied effectiveness in counteracting microglial activation, impacting CNS injury modeling.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia, the immune cells of the central nervous system (CNS), exhibit complex activation states in response to injury and disease.
  • Lipopolysaccharide (LPS) is a common in vitro and in vivo stimulus for pro-inflammatory microglia, but sterile CNS damage involves different inflammatory mediators like cytokines.
  • Rat microglia responses may differ from mouse models, and the dynamic nature of CNS inflammation necessitates understanding microglial malleability.

Purpose of the Study:

  • To compare microglial responses to lipopolysaccharide (LPS) versus pro-inflammatory cytokines (IFNγ+TNFα) in primary rat microglia.
  • To investigate the efficacy of anti-inflammatory cytokines (IL-4, IL-10) in resolving LPS- or cytokine-induced microglial activation.
  • To provide insights for more accurate in vitro modeling of microglial reactivity and in vivo transcriptional responses to CNS inflammation.

Main Methods:

  • Primary rat microglia were exposed to LPS or IFNγ+TNFα (I+T).
  • Functional outcomes (nitric oxide production, migration) and molecular responses (gene expression of ~100 genes, including sensome receptors) were analyzed.
  • Protein levels of key molecules (ARG1, CD206/MRC1, COX-2, iNOS, PYK2) were quantified, and the effects of IL-4 and IL-10 were assessed.

Main Results:

  • Microglial responses to LPS and I+T showed both similarities and notable differences, with LPS often inducing higher pro-inflammatory gene expression.
  • LPS also upregulated several anti-inflammatory genes, indicating a complex response profile.
  • Interleukin-4 (IL-4) was more effective in resolving I+T-induced responses than LPS-induced responses, while IL-10 showed limited efficacy.

Conclusions:

  • The choice of stimulus (LPS vs. cytokines) significantly impacts microglial activation profiles.
  • Interleukin-4 demonstrates differential efficacy in modulating microglial responses depending on the initial stimulus.
  • These findings are crucial for refining in vitro models of microglial activation and interpreting in vivo studies of CNS inflammation.

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
16.8K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
7.9K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
16.6K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
685